CAH
CAH N/A N/A
$0.00
+$0.00 (+0.00%)
Open: $0.00 | High: $0.00 | Low: $0.00 | Prev Close: Prev Close: $0.00
Market Cap: N/A
Volume: N/A | Avg: N/A
Last updated: April 09, 2026 at 06:01 PMInvestment Rating
Sell
Overall Score: 40/100
Rating Breakdown:
Stock Score Analysis
Stock Score: 517
Comprehensive Quality Assessment
Component Breakdown:
Valuation Metrics
| P/E Ratio | 30.76 |
| P/B Ratio | -18.98 |
| P/S Ratio | 0.21 |
| EPS | $7.06 |
| Beta | |
| Shares Outstanding | N/A |
| 52-Week High | $ |
| 52-Week Low | $ |
| SMA 50 | $ |
| SMA 200 | $ |
Financial Ratios
| Gross Margin | 3.6% |
| Operating Margin | 1.0% |
| Net Margin | 0.7% |
| ROE | -58.9% |
| ROA | 2.9% |
| Debt/Equity | -3.34 |
| Current Ratio | 0.91 |
| Quick Ratio | 0.44 |
Balance Sheet
| Total Assets | $53.12B |
| Total Liabilities | $55.76B |
| Total Equity | $-2,781,000,000 |
|
|
|
| Cash | $3.87B |
| Total Debt | $9.35B |
| Net Debt | $5.47B |
Income Statement
| Revenue | $222.58B |
| Gross Profit | $8.17B |
| Operating Income | $2.27B |
| Net Income | $1.56B |
|
|
|
| EBITDA | $3.11B |
| Revenue/Share | $1035.96 |
Cash Flow
| Operating CF | $2.40B |
| CapEx | $547.00M |
| Free Cash Flow | $1.85B |
|
|
|
| Book Value/Share | $-11.44 |
| Tangible Book/Share | $-70.67 |
| Equity/Share | $-11.44 |
Technical Indicators
| RSI (14) | 53.40 Neutral |
| MACD |
-1.19
Signal: -1.91
|
| Volatility | 20.62% |
| Trading Signal | Bullish |
Performance & Returns
Insufficient historical data
Invalid current priceSector Comparison
Sector comparison unavailable
No sector data available📊 Historical Price Analysis (Last 200 Days)
Loading chart...
Technical Analysis
| Ticker | Close | SMA 5 | SMA 8 | SMA 13 | SMA 50 | SMA 200 | RSI (14) | MACD | Volatility (%) | Volume | Signal | SMA Decision |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAH | $0.00 | $214.06 | $212.11 | $211.25 | $217.88 | $185.71 | 53.40 | -1.19 | 20.62% | 393889 | Strong Long | Bullish Stack |
Candlestick Patterns
There wasn't any recognizable pattern for the CAH stock
News Sentiment
| Ticker | Headline | Sentiment | Source | URL |
|---|---|---|---|---|
| CAH | Abacus FCF Advisors LLC Buys New Position in Cardinal Health, Inc. $CAH | Neutral | defenseworld.net | Read More |
| CAH | Why Congress Can't Stop Loading Up on These 3 Stocks in 2026 | Neutral | 247wallst.com | Read More |
| CAH | Cardinal Health (CAH) Reports Next Week: Wall Street Expects Earnings Growth | Positive | zacks.com | Read More |
| CAH | Are Investors Undervaluing Cardinal Health (CAH) Right Now? | Neutral | zacks.com | Read More |
| CAH | Cardinal Health (CAH) Stock Slides as Market Rises: Facts to Know Before You Trade | Positive | zacks.com | Read More |
Recent Insider Trading
No recent insider trading data available for CAH
Company Information
CAH is a company in the N/A sector.
| CEO | N/A |
| Employees | |
| Country | N/A |
| IPO Date | N/A |
| Exchange | N/A |
| Sector | N/A |
| Industry | N/A |
Rating Metrics Explained
DCF Score (Discounted Cash Flow)
Measures the intrinsic value of the stock based on projected future cash flows. A higher score indicates the stock is undervalued relative to its DCF valuation.
ROE Score (Return on Equity)
Evaluates how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better profitability and management effectiveness.
ROA Score (Return on Assets)
Measures how efficiently a company uses its assets to generate profit. A higher ROA means better asset utilization and operational efficiency.
D/E Score (Debt-to-Equity)
Assesses the company's financial leverage and risk. Lower debt-to-equity ratios indicate less financial risk and better balance sheet health.
P/E Score (Price-to-Earnings)
Compares stock price to earnings per share. A lower P/E ratio may indicate the stock is undervalued, while a higher ratio could suggest overvaluation or growth expectations.
P/B Score (Price-to-Book)
Compares market price to book value per share. Lower P/B ratios may indicate undervaluation relative to the company's net asset value.
Rating Recommendations:
Each metric is scored on a scale of 1-5, where the scores are determined by comparing the company's performance against industry benchmarks and historical data:
-
Strong Buy (5/5): Excellent score - strong positive indicator
- The metric significantly outperforms industry averages (top 20% of companies)
- Indicates exceptional financial health or attractive valuation in that category
-
Buy (4/5): Good score - positive indicator
- Above-average performance (top 40% of companies)
- Shows strong fundamentals with room for improvement
-
Neutral (3/5): Average score - neutral indicator
- Performance in line with industry median (middle 20%)
- Neither significantly positive nor negative signal
-
Sell (2/5): Below average - negative indicator
- Below-average performance (bottom 40% of companies)
- Suggests weakness in this particular metric
-
Strong Sell (1/5): Poor score - strong negative indicator
- Significantly underperforms industry (bottom 20%)
- Indicates potential risk or overvaluation in that category